(Q34376924)

1 August 2017

1 reference

title

Basic principles in thrombolysis: regulatory role of plasminogen (English)

1 reference

1 August 2017

1 reference

Rijken DC

1

1 reference

1 August 2017

Sakharov DV

series ordinal

2

1 reference

1 August 2017

publication date

1 September 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

103 Suppl 1

1 reference

1 August 2017

page(s)

S41-9

1 reference

A faster-acting and more potent form of tissue plasminogen activator

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Superficial accumulation of plasminogen during plasma clot lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

"Plasminogen steal" and clot lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Protein C and fibrinolysis: a link between coagulation and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Purification and characterization of a new arginine carboxypeptidase in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

The plasma carboxypeptidases and the regulation of the plasminogen system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Activation and characterization of procarboxypeptidase B from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeiden

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

High levels of coagulation factor XI as a risk factor for venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Inducible carboxypeptidase activity. A role in clot lysis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

Plasminogen-enriched pulse-spray thrombolysis with tPA: further developments

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900296-1

7 January 2021

10.1016/S0049-3848(01)00296-1

Identifiers

DOI

1 reference

1 August 2017

1 reference